GCP
FOLD

GSA Capital Partners’s Amicus Therapeutics FOLD Stock Holding History

GSA Capital Partners’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$733K Buy
+50,686
New +$727K 0.05% 665
2025
Q4 		– Sell
-51,247
Closed -$404K – 1798
2025
Q3 		$404K Sell
51,247
-5,930
-10% -$42.2K 0.03% 996
2025
Q2 		$328K Sell
57,177
-2,338
-4% -$15.1K 0.02% 1201
2025
Q1 		$486K Sell
59,515
-22,826
-28% -$211K 0.04% 824
2024
Q4 		$776K Sell
82,341
-51,459
-38% -$535K 0.06% 580
2024
Q3 		$1.43M Buy
133,800
+83,081
+164% +$905K 0.11% 250
2024
Q2 		$503K Buy
+50,719
New +$521K 0.04% 960
2023
Q1 		– Sell
-21,181
Closed -$259K – 1610
2022
Q4 		$259K Buy
+21,181
New +$238K 0.03% 1030
2022
Q3 		– Sell
-12,023
Closed -$129K – 1638
2022
Q2 		$129K Buy
+12,023
New +$99K 0.02% 1177
2021
Q4 		– Sell
-112,813
Closed -$1.08M – 1531
2021
Q3 		$1.08M Buy
+112,813
New +$1.15M 0.11% 279
2021
Q2 		– Sell
-56,077
Closed -$554K – 1400
2021
Q1 		$554K Buy
+56,077
New +$868K 0.09% 294
2020
Q4 		– Sell
-41,952
Closed -$592K – 1329
2020
Q3 		$592K Buy
+41,952
New +$611K 0.1% 302
2019
Q4 		– Sell
-13,370
Closed -$107K – 1525
2019
Q3 		$107K Buy
+13,370
New +$145K 0.01% 1269
2017
Q4 		– Sell
-20,506
Closed -$309K – 1638
2017
Q3 		$309K Buy
+20,506
New +$271K 0.02% 1224

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

GSA Capital Partners's FOLD Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Amicus Therapeutics (FOLD) in Q1 2026: 50,686 shares worth $733K. The stake represents 0.05% of the portfolio and ranks #665 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in FOLD as recently as Q3 2025.

GSA Capital Partners first reported a position in FOLD in Q3 2017 and has held it in 14 quarters since. The position peaked at $1.43M in Q3 2024. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • GSA Capital Partners held 50,686 shares of Amicus Therapeutics worth $733K as of Q1 2026.
  • Amicus Therapeutics was a new GSA Capital Partners position in Q1 2026.
  • Amicus Therapeutics made up 0.05% of GSA Capital Partners's portfolio in Q1 2026, its #665 holding.
  • GSA Capital Partners first reported a position in Amicus Therapeutics in Q3 2017 and has held it in 14 quarters since.
  • GSA Capital Partners's Amicus Therapeutics position peaked at $1.43M in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.